Ledger.Open graph →

SEC Form D · Amendment · filed August 23, 2021

SERAPH BIOSCIENCES, INC

Offering

$7.2M

Sold

$7.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

DETROIT, MI

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Scott N. Merz · Detroit, MIDirector James N. Shanley · Detroit, MIExec Braden N. Robison · Detroit, MIExec Gary Loveman · Detroit, MIDirector Charles Shanley · Detroit, MIDirector Michael Shields · Detroit, MIDirector Joshua Kligman · Bethesda, MDDirector Eric Zinterhofer · NEW YORK, NYExec John Lee · Reston, VADirector Dan Truong · Reston, VADirector Oliver Haarmann · NEW YORK, NYExec Erol Uzumeri · NEW YORK, NYDirector Ahmad N. Ishaque · Detroit, MIDirector Richard N. Creager · Detroit, MIDirector Brian Caress · Houston, TXDirector Robert Chiste · Houston, TXDirector Paul Grashei · Houston, TXDirector Paras Malde · Camana, Bay Grand Cayman, Cayman IslandsDirector Amber Ramsey · Camana, Bay Grand Cayman, Cayman IslandsExec Justin Lioi · New York, NYExec Ahmad N. Ishaque · Detroit, MIDirector Richard N. Creager · Detroit, MIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗